Showing 241 - 260 results of 75,224 for search '(( 50 a decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (mean decrease)) ))', query time: 1.12s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245

    Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG. by Joana Gil-Mohapel (462002)

    Published 2013
    “…(C) An estimation of overall neurogenesis based on the total number of BrdU-positive cells that survived the 42-day period multiplied by the proportion of BrdU-positive cells that acquired a mature neuronal phenotype indicates an age-induced significant and abrupt decrease in the overall number of new neurons. *** <i>p</i> < 0.001 between 1.5 and 3 months and between 3 and 6 months. …”
  6. 246
  7. 247
  8. 248
  9. 249
  10. 250

    Processive receptor methylation compromises adaptation and decreases signaling noise. by William Pontius (460803)

    Published 2013
    “…(C) Increasing processivity also decreases the magnitude of fluctuations in <i>a</i>(<i>t</i>) in the adapted state around the mean value <i>a</i><sub>0</sub>. …”
  11. 251

    The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

    Published 2014
    “…<p>(<b>A</b>) Genome-wide expression of 5′ splice sites, 3′ splice sites, and introns are increased relative to exons upon treatment of HeLa cells with isoginkgetin (30 µM, 18 hours), based on total RNA-Seq (dUTP method <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone.0089673-Parkhomchuk1" target="_blank">[18]</a>, Illumina). …”
  12. 252
  13. 253
  14. 254
  15. 255

    Zinc exposure decreases NR1 clusters and NMDA currents. by Jia Zhu (135506)

    Published 2012
    “…Scale bar, 50 µm. (B) and (C) show the quantification of (A). …”
  16. 256
  17. 257

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”
  18. 258
  19. 259
  20. 260